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Choline, a dietary compound present in many foods, has re-
cently been classified as an essential nutrient for humans.
There is evidence from animal models that the availability of
choline during the prenatal period influences neural and cogni-
tive development. Here we report that choline supplementation
during a 6 d gestational period protects against neurodegen-
eration in the posterior cingulate and retrosplenial cortices of
female adolescent rats produced by peripheral administration
of the NMDA receptor antagonist dizocilpine (MK-801). These
data show that availability of a single nutrient, choline, during a
brief period of prenatal development diminishes vulnerability to
neurotoxicity in adolescent offspring.
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Poor nutrition early in life, as well as perinatal insults such as
exposure to alcohol or other neurotoxins, have been linked to a
variety of abnormalities in brain development and behavior.
Thus, there is much interest in ensuring that pregnant and lac-
tating women consume a diet that is rich in nutrients necessary
for the proper physical and cognitive development of children. An
example is the recent public health policy initiative in the United
States designed to reduce the incidence of neural tube defects in
newborns by supplementing all grain products with folic acid to
ensure high folate consumption by American women.
Choline, although less well studied than folate, is also an
essential nutrient. In recognition of its key role during develop-
ment, the recommended daily intake of this compound is higher
during pregnancy and lactation (Zeisel and Blusztajn, 1994;
Blusztajn, 1998). Although choline is available in many foods, the
normal dietary sources may prove to be insufficient during times
of heightened need, such as pregnancy and lactation (Zeisel and
Blusztajn, 1994). Because choline is particularly important during
fetal development, dietary supplementation during this time
could provide long-lasting benefits.
Recent studies in animal models have indicated that prenatal
choline supplementation does indeed produce enduring enhance-
ments of CNS function. For example, prenatal choline supple-
mentation has been shown to increase phospholipase-D activity
in the hippocampus of adult offspring (Holler et al., 1996) and to
decrease acetylcholine esterase activity in the hippocampus of
juvenile offspring (Cermak et al., 1999). These changes are con-
sistent with the improvements in spatial (Meck et al., 1988;
Williams et al., 1998) and temporal (Meck and Williams, 1997)
memory observed in adult offspring after prenatal choline sup-
plementation, as well as with enhancement of NMDA receptor-
mediated neurotransmission (Montoya and Swartzwelder, 2000)
and long-term potentiation (Pyapali et al., 1998) in hippocampal
slices from prenatally choline-supplemented rats.
Prenatal choline supplementation has also been shown to pro-
tect against the memory deficits that occur after severe
pilocarpine-induced seizures (Yang et al., 2000). This finding
suggests that prenatal choline supplementation may provide pro-
tection against postnatal neurotoxicity. Because of our interest in
neurotoxicity from drugs of abuse, we were interested in whether
this supplementation could protect against the neurotoxicity in
the cingulate gyrus produced by NMDA receptor antagonists,
several of which are drugs of abuse, including ethanol, ketamine,
and phencyclidine. To test this hypothesis, we provided dietary
choline supplementation to pregnant rat dams during a 6 d period
and then measured the neurotoxic effect of the NMDA receptor
antagonist dizocilpine (MK-801) on the offspring during
adolescence.
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MATERIALS AND METHODS
Prenatal choline treatment. Pregnant Sprague Dawley rats were obtained
from Charles River (Raleigh, NC) at day 9 of gestation [embryonic day
9 (E9)] and housed individually in clear polycarbonate cages (27.9 
27.9  17.8 cm 3) on a 12 hr light /dark cycle at the Durham Veterans
Affairs Medical Center vivarium. From the day of arrival, dams were
given tap water and purified Dyets formula AIN-76A (Dyets Inc., Beth-
lehem, PA) containing the standard amount of choline (7.9 mmol/kg
choline chloride) ad libitum. This provided an average daily choline
intake of 1.3 mmol/kg. During E12–E17, choline chloride (25 mM)-
supplemented drinking water was given to one group of dams (“supple-
mented”). The other group was given water with no added choline
(“nonsupplemented”). The average total water intake across days E12–
E17 was 158 gm for control dams and 149 gm for those receiving choline
supplementation. This resulted in an average daily choline intake of 4.6
mmol/kg for the supplemented group, whereas the nonsupplemented
group continued to receive the standard amount (1.3 mmol  kg1  d1).
In both groups, saccharine (50 mM) was used to neutralize the bitter taste
of choline in the water and to equalize intake among dams in the
treatment groups. The E12–E17 time frame was chosen because it is a
critical period during which manipulation of dietary choline results in
both behavioral (Meck et al., 1988; Meck and Williams, 1997; Williams et
al., 1998) and electrophysiological (Pyapali et al., 1998; Montoya and
Swartzwelder, 2000) changes in offspring.
After E17, all dams were placed back on regular tap water (i.e.,
without choline or saccharine) and continued on the normal AIN-76A
diet. Within 24 hr after birth, the pups were cross-fostered between the
dams to litters of equal size (n  12–14/ litter). Pups were weaned at
postnatal day 22 (P22), housed four to a cage, and provided the AIN-76A
diet (i.e., with a standard choline level) and water ad libitum.
Drug treatment. A total of 16 male and 16 female offspring from a total
of five litters were used for this study. One-half of the rats of each gender
were given MK-801 (5 mg/kg, at 1 ml/kg injection volume, i.p.; RBI-
Sigma, St. Louis, MO) on P39, and the other one-half were administered
MK-801 on P42. At the time of MK-801 injection, the average body
weights (in grams) were 190 (4 SEM, male, control), 180 (3.2 SEM,
male, supplemented), 141 (6.2 SEM, female, control), and 137 (3.7
SEM, female, supplemented). This dose of MK-801 has been shown to
produce neurotoxicity in young rats (Olney et al., 1991; Fix et al., 1995;
Corso et al., 1997). Saline-injected controls were not used, because
previous studies have shown that positive neurons are almost never seen
with Fluoro-Jade (FJ) staining in saline-injected rats (Schmued et al.,
1997). This was demonstrated clearly in a similar study designed to study
the effects of agents that were protective against NMDA receptor
antagonist-induced neurotoxicity (Olney et al., 1991).
Histology. At 3 days after MK-801 injection, the rats were weighed,
anesthetized with Halothane, and perfused transcardially with 150 ml of
heparinized saline followed by 250 ml of 4% paraformaldehyde. The
brains were removed and post-fixed in 4% paraformaldehyde overnight,
transferred to 0.1 M phosphate buffer (PB) for 1 d, and then soaked in
30% sucrose in 0.1 M PB for 3–5 d until sinking. Cryostat sections (40
m) were cut and stored in 0.1 M PB at 4°C.
The sections were processed for staining with FJ-B or with the older,
related fluorochrome, FJ. Sections from all of the animals were stained
with FJ-B, and the cell numbers from these sections were used for all
statistical analyses. Alternating sections from one-half of the animals
from each treatment group were stained with FJ as an internal compar-
ison of the methods and for purposes of illustration. The staining meth-
ods were as described previously (Schmued et al., 1997; Schmued and
Hopkins, 2000). Both FJ and FJ-B provided similar staining patterns with
respect to the anatomical regions stained, the number of positive neurons
per region, and agreement between the individuals doing the counting.
FJ provided better staining of neuronal processes, and so was used for
photographic images (Fig. 1). FJ-B showed less background staining (and
positive neurons stood out more clearly, facilitating counting), and so was
used for quantitative measures. Twelve serial sections (approximately
every seventh section) from each animal were selected in a rostral-to-
caudal orientation and comprised 3.5 mm along the anteroposterior axis
of the cingulate cortex (CC) and retrosplenial cortex (RSC) (0.3 to
3.8 mm from bregma; see Fig. 3A,B). Sections were mounted from
distilled water onto 0.5% gelatin-coated slides and air-dried at room
temperature overnight. Slides were then processed in the following
solutions: 100% ethanol (3 min), 70% ethanol (1 min), distilled water (1
min), 0.06% potassium permanganate (7 min with slow shaking), distilled
water (1 min), 0.01% FJ or 0.004% FJ-B (Histo-Chem Inc., Jefferson,
AR) (in 0.1% acetic acid) for 30 min (FJ) or 20 min (FJ-B) with slow
shaking in the dark, and distilled water (three times for 1 min). Slides
were then air-dried in the dark for at least 2 hr (but not 2 d); dehydrated
in 70, 95, and 100% ethanol; placed in xylene; and then coverslipped
with distyrene plasticizer xylene (Electron Microscopy Sciences, Washing-
ton, PA).
The stained sections were examined with a Nikon (Tokyo, Japan)
epifluorescence microscope using a FITC filter. Neurotoxicity was as-
sessed by an individual who was blind to the treatment condition of the
animals from which sections were taken. In the CC–RSC region, bilateral
FJ-positive cell counts were made from 12 serial sections (see Fig. 3).
Some FJ-stained sections (four each from supplemented and non-
supplemented animals) were counterstained with hematoxylin and eosin
(H&E) using standard methods (Fig. 1). Three measures of neurodegen-
eration were qualitatively assessed by visual inspection: nuclear size,
condensation, and an eosinophilic cell body. Four sections per animal in
both supplemented and nonsupplemented groups were also stained for
neurodegeneration using a silver staining kit (FD NeuroTechnologies,
Ellicott City, MD). Degenerating neurons were assessed under a light
microscope (by visual inspection).
Statistical analysis. The data from FJ-positive cell counts were ana-
lyzed using a two-way ANOVA with dietary treatment condition and day
of MK-801 administration as between-subjects factors and histological
section as the within-subjects factor. Comparisons of particular histolog-
ical sections across dietary treatment groups were made using parametric
post hoc tests where appropriate and secondary to the overall ANOVA.
RESULTS
Consistent with previous findings, administration of MK-801
caused degeneration of neurons in the CC–RSC (Olney et al.,
1989; 1991), as evidenced by FJ staining (Fig. 1A,B) (Schmued
and Hopkins, 2000), and varied across the rostral-to-caudal sec-
tions that were analyzed (Fix et al., 1995; Corso et al., 1997).
As reported previously, females were more sensitive than males
to NMDA receptor antagonist-induced neurotoxicity (Hönack
and Löscher, 1993; Fix et al., 1995). Very little neuronal damage
was observed in male offspring of either age. Of a total of 16 male
rats tested, only 3 rats showed any FJ-positive stained neurons,
and in those rats, the maximum number of stained neurons in any
section was eight. The average number of positively stained
neurons per section was 0.16 (0.09 SEM) in sections from
control males, and 0.3 (0.11 SEM) in sections from prenatally
choline-supplemented animals. This minimal amount of positive
staining in sections from males precluded any statistical compar-
isons between control and choline-supplemented males. There-
fore, all subsequent analyses were performed on females.
In FJ-stained sections, degenerating neurons have a bright
yellowish-green soma against a dark green background. Some
neurons were clearly pyramidal in shape, and in some neurons
proximal processes were also stained. In the sections from control
animals, 80% (SD  2) of the FJ-positive neurons were pyrami-
dal; in sections from prenatally choline-supplemented animals,
83% (SD  4.5) were pyramidal. This difference was not statis-
tically significant (t(8)  1.462; p  0.18). Neurodegeneration was
most prominent in deep cortical layers, consistent with typical
NMDA receptor antagonist-induced neurotoxicity, in which cor-
tical layers III and IV are the most affected (Olney et al., 1989,
1991). To further confirm that FJ-positive neurons were indeed
degenerating, we stained representative sections from supple-
mented and nonsupplemented female rats with two other widely
used methods to assess neurodegeneration: H&E and silver.
Some FJ-stained sections were also counterstained with H&E (FJ
plus H&E). In these sections, all FJ-positive neurons showed
degeneration characterized by eosinophilic staining of the soma
and proximal dendrites. Figure 1C shows a FJ plus H&E coun-
terstained section in two views (Fig.1C1, FJ; Fig. 1C2, H&E). As
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shown in Figure 2, silver staining revealed neurodegeneration in
the same layers as FJ staining.
Prenatal choline supplementation provided significant protec-
tion against MK-801-mediated neurotoxicity in female rats. Fig-
ure 3C shows the number of FJ-B-positive neurons in sections
from choline-supplemented and nonsupplemented female ani-
mals that were treated with MK-801 on P39 (Fig. 3C, lef t) or P42
(Fig. 3C, right). The ANOVA revealed significant main effects for
both dietary choline treatment (F(1,12)  17.33; p  0.001) and
day of MK-801 treatment (F(1,12)  5.35; p  0.039). In addition,
the number of FJ-B-positive neurons varied significantly across
the 12 sections analyzed (F(11)  34.32; p  0.0009). There was a
significant interaction between this effect and the main effect of
dietary treatment (F(11)  6.98; p  0.0009), indicating that the
effect of choline treatment varied with the rostrocaudal depth of
the sections analyzed.
DISCUSSION
Dietary choline supplementation during gestation protected
against MK-801-induced neurotoxicity in adolescent offspring.
This finding is striking because it indicates that moderate dietary
supplementation with an essential nutrient during a brief period
of prenatal development produces an enduring neuroprotective
Figure 1. Fluoro-Jade staining of sections from MK-801-treated nonsupplemented (A) and choline-supplemented (B) female rats. A1 and B1 show a
low-magnification view (10 magnification). Scale bar, 200 m. Boxes in A1 and B1 indicate areas enlarged in A2 and B2 (40 magnification). Scale bar,
50 m. C, Fluoro-Jade-positive stained neurons (C1) counterstained with H&E (C2): (100 magnification). Scale bar, 20 m. Arrowheads show
degenerating neurons. Sections were taken from between approximately 2.00 and 2.25 mm relative to bregma.
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effect on the offspring. This result is quite unique because most
studies of prenatal dietary manipulations have focused on the
negative outcomes of nutritional deficiency rather than on posi-
tive outcomes of supplementation.
The mechanisms underlying NMDA receptor antagonist-
induced toxicity are not well understood. However, there is evi-
dence from in vivo (Olney et al., 1991; Sharp et al., 1994, 2001;
Tomitaka et al., 2000) and in vitro (Li et al., 2000) studies that
inhibitory processes may be involved. Based on those findings, it
has been proposed that NMDA receptor antagonists cause neu-
rodegeneration by blocking NMDA receptor-mediated excitatory
inputs onto inhibitory interneurons, and this could create a state
of disinhibition sufficient to render the principle neurons vulner-
able to excitotoxicity.
We do not know whether choline supplementation provides
protection by directly opposing excitotoxicity or by indirectly
interacting with modulatory processes. One possibility is that it
does so through a cholinergic mechanism. Previous studies have
shown that prenatal choline supplementation causes increased
release of acetylcholine in offspring (Cermak et al., 1998), and
stimulation of nicotinic cholinergic receptors is known to be
neuroprotective against some neurotoxic processes (Belluardo et
al., 2000). Perhaps supplemented animals activate more nicotinic
receptors and are therefore protected against NMDA receptor
antagonist toxicity. However, other studies have shown that
NMDA receptor antagonist toxicity is reduced by muscarinic
cholinergic antagonists. This would suggest that muscarinic re-
ceptors somehow mediate a toxic process. Prenatal choline sup-
plementation could also act through more general mechanisms.
For example, acetylcholine has morphogenetic actions during
brain development (Lauder and Schambra, 1999), and thus could
influence a number of processes that could prove to be neuro-
protective. Clearly more studies are needed to adequately test
these hypotheses.
The ability of prenatal choline supplementation to enhance
CNS function and decrease vulnerability to neurotoxicity may
have wide-ranging implications. For example, the age at which we
first treated animals in this study (P39) is shortly after the onset
of vulnerability to MK-801-induced neurotoxicity (Farber et al.,
1995; Auer, 1996), and also is within the periadolescent period of
development in rats (Odell, 1990; Witt, 1994). Thus, the present
results have implications for adolescent health, in that it is during
Figure 2. I llustration of silver staining of sections from MK-801-treated nonsupplemented (A) and choline-supplemented (B) female rats. (A1 and B1:
40 magnification). Scale bar, 50 m. Arrowheads in A1 and B1 show the same degenerating neurons magnified in A2 and B2 (100 magnification). Scale
bar, 20 m. Sections were taken from between approximately 2.00 and 2.25 mm relative to bregma.
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adolescence that many individuals initiate recreational use of a
variety of psychoactive compounds, including NMDA receptor
antagonists such as phencyclidine, ketamine, and alcohol. We also
observed that the protective effect of prenatal choline supplemen-
tation was greater when MK-801 treatment was delayed several
days later into adolescent development (P42). This is consistent
with previous studies that have shown that the neurotoxicity of
MK-801 increases with age into adulthood (Farber et al., 1995;
Auer, 1996). It is not known whether the neuroprotective effect of
prenatal choline supplementation persists into adulthood, but
studies are currently underway in our laboratory to assess that
possibility.
In addition to recreational use, NMDA receptor antagonists
have been used clinically, although their use in humans has been
curtailed because of unacceptable behavioral side effects. The
present results suggest a possible approach toward enhancing
resistance to NMDA receptor antagonist toxicity that could lead
to strategies that would allow the safe therapeutic use of these
compounds.
Perhaps even more intriguing is the possibility that prenatal
dietary choline manipulation could decrease the vulnerability to
some psychiatric illnesses. Converging lines of evidence suggest
that the type of neuronal injury that occurs after exposure to
NMDA receptor antagonists may be related to the onset or acute
manifestation of psychosis (Ellison, 1995; Farber et al., 1995).
Developmentally, the onset of psychotic schizophrenic symptoms
in humans generally does not occur until adolescence or early
adulthood (Rapoport et al., 1997), a developmental onset that is
consistent with the onset of toxic liability to NMDA receptor
antagonists in rats (Farber et al., 1995; Auer, 1996). In addition,
abnormalities in both the cingulate gyrus (Shergill et al., 2000;
Tamminga et al., 2000) and thalamic nuclei that modulate cingu-
late activity (Shergill et al., 2000; Sharp et al., 2001) have been
implicated in the etiology of psychosis. Finally, drugs that ame-
liorate or prevent psychotic symptoms, such as haloperidol and
olanzapine, also attenuate NMDA receptor antagonist-induced
neurotoxicity (Sharp et al., 1994; Farber et al., 1996). Thus,
prenatal choline supplementation, as a treatment that protects
against NMDA receptor antagonist-induced neurotoxicity, could
potentially diminish the likelihood of psychosis in adolescents or
young adults.
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